Dual Role of Inflammasome Adaptor ASC in Cancer

Apoptosis-associated Speck-like protein containing a CARD (caspase activation and recruitment domain) (ASC), also called PYCARD/Target of Methylation-induced Silencing-1 (TMS1), was originally discovered as a protein that forms aggregates (“specks”) in human leukemia cells treated with chemotherapeu...

Full description

Bibliographic Details
Main Authors: Maria Pia Protti, Lucia De Monte
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcell.2020.00040/full
_version_ 1818549487024472064
author Maria Pia Protti
Maria Pia Protti
Lucia De Monte
Lucia De Monte
author_facet Maria Pia Protti
Maria Pia Protti
Lucia De Monte
Lucia De Monte
author_sort Maria Pia Protti
collection DOAJ
description Apoptosis-associated Speck-like protein containing a CARD (caspase activation and recruitment domain) (ASC), also called PYCARD/Target of Methylation-induced Silencing-1 (TMS1), was originally discovered as a protein that forms aggregates (“specks”) in human leukemia cells treated with chemotherapeutic agents. Its expression was found to be silenced by methylation in many human tumors, preventing tumor cells from undergoing apoptosis and supporting its role as a tumor suppressor. Subsequently, ASC was also identified as a central adaptor molecule of the inflammasome complex, which mediates the secretion of inflammatory cytokines (i.e., IL-1β and IL-18). Inflammatory cytokines have been shown to mediate tumor-promoting functions. Thus, in the context of cancer development and progression, ASC may exert opposing functions, i.e., be either tumor-suppressing by inducing tumor cell apoptosis, or tumor-promoting by favoring secretion of inflammatory cytokines (by tumor cells and/or tumor infiltrating myeloid cells) within the tumor microenvironment. Here, we report and discuss this dual role of ASC by also considering the final contribution of each of its two main functions in several cancer types, taking into consideration the correlation between ASC expression, clinical correlates, and patients’ survival. ASC and inflammasome targeting strategies are being developed. However, before the use of such treatments in clinical practice, it is fundamental to better dissect the role of ASC in different tumors, in order to privilege or avoid their use in those tumors in which ASC exerts an anti-tumor or pro-tumor function, respectively.
first_indexed 2024-12-12T08:33:58Z
format Article
id doaj.art-5f3c123021a44a688728e5063c57acfc
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-12-12T08:33:58Z
publishDate 2020-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-5f3c123021a44a688728e5063c57acfc2022-12-22T00:30:59ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2020-02-01810.3389/fcell.2020.00040521272Dual Role of Inflammasome Adaptor ASC in CancerMaria Pia Protti0Maria Pia Protti1Lucia De Monte2Lucia De Monte3Tumor Immunology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, ItalyDivision of Immunology, Transplantation and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, ItalyTumor Immunology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, ItalyDivision of Immunology, Transplantation and Infectious Diseases, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) San Raffaele Scientific Institute, Milan, ItalyApoptosis-associated Speck-like protein containing a CARD (caspase activation and recruitment domain) (ASC), also called PYCARD/Target of Methylation-induced Silencing-1 (TMS1), was originally discovered as a protein that forms aggregates (“specks”) in human leukemia cells treated with chemotherapeutic agents. Its expression was found to be silenced by methylation in many human tumors, preventing tumor cells from undergoing apoptosis and supporting its role as a tumor suppressor. Subsequently, ASC was also identified as a central adaptor molecule of the inflammasome complex, which mediates the secretion of inflammatory cytokines (i.e., IL-1β and IL-18). Inflammatory cytokines have been shown to mediate tumor-promoting functions. Thus, in the context of cancer development and progression, ASC may exert opposing functions, i.e., be either tumor-suppressing by inducing tumor cell apoptosis, or tumor-promoting by favoring secretion of inflammatory cytokines (by tumor cells and/or tumor infiltrating myeloid cells) within the tumor microenvironment. Here, we report and discuss this dual role of ASC by also considering the final contribution of each of its two main functions in several cancer types, taking into consideration the correlation between ASC expression, clinical correlates, and patients’ survival. ASC and inflammasome targeting strategies are being developed. However, before the use of such treatments in clinical practice, it is fundamental to better dissect the role of ASC in different tumors, in order to privilege or avoid their use in those tumors in which ASC exerts an anti-tumor or pro-tumor function, respectively.https://www.frontiersin.org/article/10.3389/fcell.2020.00040/fullASC/TMS1tumor cellsmyeloid cellstumor suppressor geneinflammasomeIL1
spellingShingle Maria Pia Protti
Maria Pia Protti
Lucia De Monte
Lucia De Monte
Dual Role of Inflammasome Adaptor ASC in Cancer
Frontiers in Cell and Developmental Biology
ASC/TMS1
tumor cells
myeloid cells
tumor suppressor gene
inflammasome
IL1
title Dual Role of Inflammasome Adaptor ASC in Cancer
title_full Dual Role of Inflammasome Adaptor ASC in Cancer
title_fullStr Dual Role of Inflammasome Adaptor ASC in Cancer
title_full_unstemmed Dual Role of Inflammasome Adaptor ASC in Cancer
title_short Dual Role of Inflammasome Adaptor ASC in Cancer
title_sort dual role of inflammasome adaptor asc in cancer
topic ASC/TMS1
tumor cells
myeloid cells
tumor suppressor gene
inflammasome
IL1
url https://www.frontiersin.org/article/10.3389/fcell.2020.00040/full
work_keys_str_mv AT mariapiaprotti dualroleofinflammasomeadaptorascincancer
AT mariapiaprotti dualroleofinflammasomeadaptorascincancer
AT luciademonte dualroleofinflammasomeadaptorascincancer
AT luciademonte dualroleofinflammasomeadaptorascincancer